Celldex Therapeutics | CLDX - Net Income

Stock Price
29.51
Daily Change
4.67 18.78%
Monthly
11.05%
Yearly
41.85%
Q1 Forecast
22.31

Celldex Therapeutics reported $-67.04M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
AbbVie USD 1.82B 1.63B Dec/2025
Agenus USD -25.27M 20.59M Mar/2025
Amgen USD 1.33B 1.88B Dec/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Celldex Therapeutics USD -67.04M 10.44M Sep/2025
Glaxosmithkline GBP 2.71B 1.27B Sep/2025
Nektar Therapeutics USD -37.06M 15.31M Sep/2024
Northwest Biotherapeutics USD -19.37M 1.5M Sep/2024
Pfizer USD -1.65B 5.19B Dec/2025
Rigel Pharmaceuticals USD 12.42M 13.45M Sep/2024
Roche Holding CHF 5.47B 1.76B Dec/2025